Abstract:Mortality from cancer is almost exclusively due to metastasis to distant organs. Therefore, understanding the biology of tumor metastasis is the most significant challenge in cancer research today. The tumor microenvironment is central in supporting tumor growth. However, the role of the metastatic microenvironment in the multistage process of metastasis is largely unresolved. Since each metastatic microenvironment exerts specific functions that support or oppose colonization by disseminated tumor, understanding distinct organ-specific mechanisms that enable metastatic growth is of crucial importance. Utilizing mouse models of breast cancer metastasis to lungs, brain and bone, combined with clinical data from patients with metastatic disease, we uncover the mechanisms that underlie the early events of metastasis to provide the mechanistic basis for therapeutic targeting to reduce metastatic relapse. Our findings reveal organ-specific co-evolution of stromal and immune cells at distinct metastatic niches, that lead to the formation of an immunosuppressive microenvironment, permissive to metastatic growth. Analysis of human metastasis reveal that these pathways are also operative in human disease. We show that genetic and/or pharmacological targeting of specific nodes in the interactions between stromal and immune cells results in attenuated metastasis and improved survival. Our findings imply that combinatorial therapeutic strategies to target the crosstalk between stromal and immune cells at the metastatic microenvironment may be a promising treatment strategy to inhibit metastatic relapse. Citation Format: Neta Erez. Stromal and immune plasticity shape the metastatic microenvironment [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Tumor-body Interactions: The Roles of Micro- and Macroenvironment in Cancer; 2024 Nov 17-20; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2024;84(22_Suppl) nr IA013.

Phenotypic plasticity – Implications for tumours in bone

Phenotypic Plasticity and Cancer: A System Biology Perspective

Phenotypic Heterogeneity, Bidirectionality, Universal Cues, Plasticity, Mechanics, and the Tumor Microenvironment Drive Cancer Metastasis

Cellular plasticity in the breast cancer ecosystem

Bone marrow niches in the regulation of bone metastasis

Epithelial/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding?

Tumor-Stroma Interactions in Bone Metastasis: Molecular Mechanisms and Therapeutic Implications.

Epithelial-mesenchymal plasticity: How have quantitative mathematical models helped improve our understanding?

Cell Heterogeneity and Phenotypic Plasticity in Metastasis Formation: The Case of Colon Cancer

Mammary tumour cells remodel the bone marrow vascular microenvironment to support metastasis

Abstract IA024: Cellular plasticity during metastatic colony formation in patients

Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness

Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression

Multiple influence of immune cells in the bone metastatic cancer microenvironment on tumors

The bone microenvironment invigorates metastatic seeds for further dissemination

Abstract IA013: Stromal and immune plasticity shape the metastatic microenvironment

Understanding the Bone in Cancer Metastasis

Novel approaches to target the microenvironment of bone metastasis

Epithelial-mesenchymal plasticity: emerging parallels between tissue morphogenesis and cancer metastasis

Evolution of phenotypic plasticity leads to tumor heterogeneity with implications for therapy

The metastasis-promoting roles of tumor-associated immune cells